United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $201,061 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $816,254 | | tax credit/rebate |
United Therapeutics | United Therapeutics | North Carolina | state | 2012 | $155,750 | | grant |
Lung Biotechnology, Inc. | United Therapeutics | North Carolina | state | 2016 | $2,270 | | tax credit/rebate |
Lung Biotechnology, Inc. | United Therapeutics | North Carolina | state | 2015 | $5,694 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2016 | $6,188 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2016 | $141,841 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2016 | $194,803 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | North Carolina | state | 2015 | $415,729 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2015 | $666,542 | | tax credit/rebate |
United Therapeutics Corporation and Subsidiaries | United Therapeutics | Maryland | state | 2015 | $72,866 | | tax credit/rebate |
United Therapeutics Corporation and Subsidiaries | United Therapeutics | Maryland | state | 2016 | $86,740 | | tax credit/rebate |
United Therapeutics Corporation and Subs. | United Therapeutics | Maryland | state | 2017 | $54,182 | | tax credit/rebate |
United Therapeutics | United Therapeutics | Maryland | local | 2018 | $500,000 | | grant/loan hybrid program |
United Therapeutics Corporation & Subs. | United Therapeutics | Maryland | state | 2018 | $74,842 | | tax credit/rebate |
United Therapeutics Corporation & Subs | United Therapeutics | Maryland | state | 2019 | $129,675 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2017 | $143,927 | | tax credit/rebate |
United Therapeutics Corp | United Therapeutics | North Carolina | state | 2010 | $619,566 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2020 | $41,168 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2021 | $49,887 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2022 | $34,500 | | tax credit/rebate |
United Therapeutics Corp | United Therapeutics | North Carolina | state | 2011 | $64,525 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2017 | $52,393 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2018 | $160,733 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $181,443 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2016 | $284,933 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2015 | $404,026 | | tax credit/rebate |
Ultragenyx Pharmaceutical, Inc. | Ultragenyx Pharmaceutical | California | state | 2014 | $2,100,000 | | tax credit/rebate |
ULTRAGENYX PHARMACEUTICAL INC | Ultragenyx Pharmaceutical | Pennsylvania | state | 2020 | $34,700 | | tax credit/rebate |
Ultragenyx Pharmaceutical | Ultragenyx Pharmaceutical | Massachusetts | state | 2020 | $780,952 | | tax credit/rebate |
Ultragenyx Pharmaceutical Inc | Ultragenyx Pharmaceutical | Pennsylvania | state | 2021 | $53,100 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2012 | $296,213 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2013 | $57,596 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2013 | $42,180 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2016 | $11,847 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2015 | $132,577 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2016 | $139,492 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2015 | $708,343 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2020 | $216,022 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2017 | $222,417 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2019 | $536,362 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2020 | $4,380 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2019 | $5,298 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2018 | $15,595 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2017 | $16,654 | | tax credit/rebate |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | | | $815,278 | loan or bond financing |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | | $200,000 | | grant |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | 2009 | $6,556 | | tax credit/rebate |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | 2010 | $53,200 | | tax credit/rebate |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | | $100,000 | | grant |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | 2011 | $118,136 | | tax credit/rebate |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | 2017 | $1,494,073 | | tax credit/rebate |
WATSON LABORATORIES, INC. | Teva Pharmaceutical Industries | California | state | 2003 | $166,452 | | training reimbursement |
WATSON PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | California | state | 2005 | $32,240 | | training reimbursement |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | New Jersey | state | 2010 | $289,800 | | tax credit/rebate |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
IVAX PHARMACEUTICALS | Teva Pharmaceutical Industries | New York | local | 2005 | $5,214 | | tax credit/rebate; property tax abatement |
Ivax Pharmaceuticals | Teva Pharmaceutical Industries | New York | local | 2007 | $4,930 | | tax credit/rebate; property tax abatement |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | Pennsylvania | state | | $150,000 | | training reimbursement |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $1,749,000 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $405,000 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $345,000 | | tax credit/rebate |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $4,000,000 | | grant |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $400,000 | | grant |
Nupathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2008 | $369,626 | | tax credit/rebate |
Nupathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2009 | $206,194 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2009 | $145,313 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2010 | $241,071 | | tax credit/rebate |
Nupathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2010 | $54,157 | | tax credit/rebate |
Cephalon | Teva Pharmaceutical Industries | Utah | state | 2009 | $1,683,200 | | tax credit/rebate |
Barr Laboratories, Inc. | Teva Pharmaceutical Industries | Virginia | state | 2008 | $400,000 | | grant |
Barr Laboratories Inc. | Teva Pharmaceutical Industries | Virginia | state | 2008 | $500,000 | | grant |
Watson Laboratories, Inc. | Teva Pharmaceutical Industries | Utah | state | 2009 | $7,450 | | training reimbursement |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $740,231 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $566,948 | | tax credit/rebate |
NuPathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $161,044 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $10,746 | | tax credit/rebate |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
Andrx/Anda Pharmaceuticals (Lexington Groveport I LLC & Anda Pharm) | Teva Pharmaceutical Industries | Ohio | local | 2009 | undisclosed | | property tax abatement |
Andrx/Anda Pharmaceuticals (Lexington Groveport I LLC & Anda Pharm) | Teva Pharmaceutical Industries | Ohio | local | 2010 | undisclosed | | property tax abatement |
Andrx/Anda Pharmaceuticals | Teva Pharmaceutical Industries | Ohio | local | 2011 | undisclosed | | property tax abatement |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | Mississippi | state | 2012 | $50,000 | | training reimbursement |
ANDRX Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 2005 | undisclosed | | tax credit/rebate |
Andrx Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | Florida | state | 2003 | undisclosed | | tax credit/rebate |
ANDRX Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 1998 | $815,500 | | tax credit/rebate |
Andrx Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 2004 | $525,000 | | tax credit/rebate |
Watson Laboratories, Inc. | Teva Pharmaceutical Industries | Florida | state | 2000 | $312,000 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $903,866 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $129,362 | | tax credit/rebate |
NuPathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $12,593 | | tax credit/rebate |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | New Jersey | state | 2011 | $569,910 | | grant |
Barr Laboratories, Inc. and Subsidiaries | Teva Pharmaceutical Industries | New Jersey | state | 2002 | $1,969,200 | | grant |
Watson Pharmaceuticals, Inc. and Affiliates | Teva Pharmaceutical Industries | New Jersey | state | 2009 | $3,038,000 | | grant |
Ivax Pharmaceuticals | Teva Pharmaceutical Industries | New York | local | 2008 | $13,095 | | tax credit/rebate; property tax abatement |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2010 | $42,015 | | tax credit/rebate |
TEVA Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2011 | $26,524 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2008 | $76,270 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2012 | $50,570 | | tax credit/rebate |
TEVA Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2009 | $41,319 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2014 | $50,570 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2013 | $5,485,485 | | tax credit/rebate |